ADR120S

ADR120S Current Liabilities

The Current Liabilities of ADR120S (3750.T) as of Nov 3, 2026 is 224.11 M JPY. In the previous year, Current Liabilities was 542.93 M JPY — a change of -58.72% (lower).

Current Liabilities

224.11 MJPY

YoY

-58.72%

Last updated:

Current Liabilities of ADR120S is 2026 224.11 M JPY. Current Liabilities of ADR120S was 2025 542.93 M JPY. It decreases by -58.72% lower compared to the previous year.

The ADR120S Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2019
996.23 M JPY
Jan 1, 2020
1.33 B JPY
Jan 1, 2021
1.26 B JPY
Jan 1, 2022
1.55 B JPY
Jan 1, 2023
1.55 B JPY
Jan 1, 2024
575.94 M JPY
Jan 1, 2025
542.93 M JPY
Jan 1, 2026
224.11 M JPY
The ADR120S Current Liabilities history
YEARCurrent LiabilitiesYoY
224.11 MJPY-58.72%
542.93 MJPY-5.73%
575.94 MJPY-62.91%
1.55 BJPY+0.25%
1.55 BJPY+23.33%
1.26 BJPY-5.81%
1.33 BJPY+33.84%
996.23 MJPY-55.83%
2.26 BJPY+1,772.06%
120.48 MJPY-82.11%
673.56 MJPY-66.66%
2.02 BJPY+81.40%
1.11 BJPY-3.85%
1.16 BJPY-29.06%
1.63 BJPY-26.92%
2.23 BJPY-29.72%
3.18 BJPY-65.83%
9.30 BJPY-15.84%
11.05 BJPY-0.19%
11.07 BJPY-21.06%
14.03 BJPY+38.83%
10.11 BJPY+130.03%
4.39 BJPY+12.64%
3.90 BJPY+21.38%
3.21 BJPY+120.37%
1.46 BJPY-16.30%
1.74 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

ADR120S Stock analysis

What does ADR120S do? ADR120S Inc generates revenue through its Real Asset segment, which involves buying and selling real estate, developing and operating hotels, and investing in real estate projects. The Medical segment focuses on regenerative medicine, selling medical equipment like the Celusion centrifuge and Celusion cell therapy kit, and providing cell therapy services. The company serves clients in real estate development, hotel operations, and healthcare sectors, with products targeting medical facilities and clinics specializing in regenerative treatments. The Real Asset segment handles property transactions, hotel management, and real estate investments, while the Medical segment offers cell therapy solutions through its branded products. Both segments target businesses seeking to expand in real estate or adopt advanced medical technologies, with the Celusion products being key revenue drivers in the healthcare market. ADR120S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADR120S stock

Current Liabilities of ADR120S is 224.11 M JPY in 2026.

Current Liabilities of ADR120S changed from 542.93 M JPY to 224.11 M JPY, representing a -58.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities ADR120S since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's ADR120S historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — ADR120S

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — ADR120S